---
title: "Standigm and CrystalGenomics announce partnership to 
discover novel therapeutics in cancer, rheumatoid arthritis and liver related diseases."
date: May 30, 2017
categories:
  - News
tags:
  - Standigm
  - CrystalGenomics
  - Artificial Intelligence
  - AI-driven drug discovery
  - Cancer
---

Standigm, Inc. and CrystalGenomics, Inc. today agree collaborative partnership with the objective to discover and develop first-in-class drugs in the multiple therapeutic areas including cancer, rheumatoid arthritis and liver related diseases.

